US Stock MarketDetailed Quotes
ZVSA ZyVersa Therapeutics
- 6.4700
- +0.0800+1.25%
Close May 7 16:00 ET
- 6.3600
- -0.1100-1.70%
Pre 08:08 ET
4.91MMarket Cap-24P/E (TTM)
6.6855High6.0600Low212.26KVolume6.2100Open6.3900Pre Close1.35MTurnover32.12%Turnover RatioLossP/E (Static)759.49KShares180.250052wk High0.44P/B4.28MFloat Cap4.440052wk Low--Dividend TTM660.78KShs Float8750.0000Historical High--Div YieldTTM9.79%Amplitude4.4400Historical Low6.3560Avg Price1Lot Size
ZyVersa Therapeutics News
Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
ZyVersa Therapeutics Analyst Ratings
Zyversa Therapeutics' 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity
ZyVersa Therapeutics Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)
Buy Rating Affirmed for ZyVersa Therapeutics Amid Promising Inflammatory and Metabolic Syndrome Treatments
HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5
ZyVersa Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: ZyVersa Therapeutics (ZVSA), Halozyme (HALO) and Nurix Therapeutics (NRIX)
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg